“The MELODY Study”
Some exciting news for liver patients about a new study starting today.
The MELODY Study aims to assess antibody responses following three Covid-19 vaccine doses in immunocompromised people. It will include people who have received solid organ transplants, people with rare autoimmune diseases receiving immunosuppression and people who had a diagnosis of blood cancer. It aims to recruit 12,000 solid organ transplant patients.
For more information, and to register, go to www.melodystudy.org
